Linden Advisors’s Ibere Pharmaceuticals Warrants IBER.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.WS
Linden Advisors's IBER.WS Position: Q1 2023 in Review
Linden Advisors sold out of Ibere Pharmaceuticals Warrants (IBER.WS) in Q1 2023, closing a stake of 192,734 shares — an estimated $2.1K sold.
Linden Advisors first reported a position in IBER.WS in Q2 2021 and held it in 7 quarters. The position peaked at $169K in Q2 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.
- Linden Advisors reported no remaining Ibere Pharmaceuticals Warrants position as of Q1 2023 after selling out during the quarter.
- Linden Advisors sold 192,734 Ibere Pharmaceuticals Warrants shares in Q1 2023, an estimated $2.1K.
- Linden Advisors first reported a position in Ibere Pharmaceuticals Warrants in Q2 2021 and held it in 7 quarters.
- Linden Advisors's Ibere Pharmaceuticals Warrants position peaked at $169K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Warrants as of Q1 2023.
Based on Linden Advisors's 13F filing for Q1 2023, filed 15 May 2023.